Tag: pharma
Showing 24 out of 48 results
11 April 2022
UPC hopes to be operational by end of 2022 or early 2023 and opt-out sunrise period to start immediately Germany deposits instrument of ratification
28 March 2022
"The UPC and the unitary patent - the time is now" HSF feature article in PLC Magazine (part 2)
04 March 2022
New Clinical Trial Regulation now live
28 February 2022
HSF feature article in PLC Magazine on the UPC and unitary patent (part 1)
14 May 2021
Emma and Rebekah Talk IP: COVID-19 vaccines and patent waiver rights
23 March 2021
Judicial review - another weapon in Big Pharma's disputes arsenal?
28 January 2021
Challenges to German ratification of the UPC Agreement trigger delay but possibly not for long
11 January 2021
The Trade and Cooperation Agreement and its impact on IP, Pharma and Medical Devices
08 December 2020
As the Bundestag passes the legislation to ratify the UPC Agreement, the UPC may finally open its doors in 2022
16 November 2020
Approach to assessing entitlement to priority unchanged – TBA in the CRISPR case confirms
11 November 2020
Consultation on MHRA draft guidance on the licensing of biosimilar products post transition – open until 15 November 2020
17 September 2020
Glaxo’s purple inhalers fail to get trade mark protection
Showing 24 out of 48 results
View more